Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹-1,245 Cr₹-1,066 Cr₹-1,049 Cr₹-1,805 Cr₹-1,655 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹-1,245 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹-1,245 Cr
Mar2025₹-1,066 Cr
Mar2024₹-1,049 Cr
Mar2023₹-1,805 Cr
Mar2022₹-1,655 Cr

How is Deferred Tax Assets / Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹-1,245 Cr
Negative
Mar2025 ₹-1,066 Cr
Negative
Mar2024 ₹-1,049 Cr
Negative
Mar2023 ₹-1,805 Cr
Negative
Mar2022 ₹-1,655 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹64,594.2 Cr -4.4% -6.9% 16.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,120.0 Cr -3.2% -5.4% 12% Stock Analytics
DIVIS LABORATORIES ₹253,390.0 Cr 0.7% 3.2% 61.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,740.0 Cr -2.8% -3% 32.6% Stock Analytics
CIPLA ₹108,497.0 Cr -2.9% -3.3% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹100,925.0 Cr -3.3% 4.7% -2.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-4.4%

-6.9%

16.5%

SENSEX

-2.1%

-5.9%

-10.8%


You may also like the below Video Courses